𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells

✍ Scribed by Maria Serova; Fabien Calvo; François Lokiec; Florence Koeppel; Virginie Poindessous; Annette K. Larsen; Emily S. Van. Laar; Stephen J. Waters; Esteban Cvitkovic; Eric Raymond

Publisher
Springer
Year
2005
Tongue
English
Weight
362 KB
Volume
57
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhancement of cisplatin activity by lon
Enhancement of cisplatin activity by lonidamine in human ovarian cancer cells
✍ Rosella Silvestrini; Nadia Zaffaroni; Raffaella Villa; Linda Orlandi; Aurora Cos 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 524 KB

The ability of lonidamine, an energolytic derivative of indazolecarboxylic acid, to modulate the cytotoxicity of cisplatin was investigated in human ovarian-cancer cell lines sensitive (A2780) or with experimentally induced resistance (A2780/cp8) to the alkylating agent. A 24-hr post-incubation with

Comparative cytotoxicity of CI-973, cisp
Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines
✍ R. P. Perez; P. J. O'Dwyer; L. M. Handel; R. F. Ozols; T. C. Hamilton 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 528 KB

## Abstract The clinical efficacy of cisplatin‐based chemotherapy for ovarian cancer is frequently compromised by drug resistance or dose‐limiting renal and neurologic toxicities. CI‐973 (NK‐121), a 2‐methyl‐1, 4‐butanediamine analogue of carboplatin, has shown little nephro‐and neuro‐toxicity in p